Business
MedX Health Corp Reports Financial Results 2nd Quarter 2010
MedX Health Corp Reports Financial Results 2nd Quarter 2010
About this update from Medx Health Corp.
[{"type":"text","content":"\n\n\n\n Aug. 30, 2010 (Canada NewsWire Group) -- \n\n \n \n \nTR.cnwUnderlinedCell TD {\n BORDER-BOTTOM: #000000 1px solid\n}\nTR.cnwDoubleUnderlinedCell TD {\n BORDER-BOTTOM: #000000 3px double\n}\nTR.cnwBoldUnderlinedCell TD {\n BORDER-BOTTOM: #000000 3px solid\n}\nTD.cnwUnderlinedCell {\n BORDER-BOTTOM: #000000 1px solid\n}\nTD.cnwDoubleUnderlinedCell {\n BORDER-BOTTOM: #000000 3px double\n}\nTD.cnwBoldUnderlinedCell {\n BORDER-BOTTOM: #000000 3px solid\n}\n\n\n MedX Health Corporation Issues Shares for Debt\n \n\n Sets Annual and Special Meeting of Shareholders Date\n \n\n MISSISSAUGA, ON, Aug. 30 /CNW/ - MedX Health Corp., (TSXV.MDX) a\n global leader in drug free, non-invasive low level laser and light\n therapy for tissue repair and pain relief, today announced revenue for\n the quarter ended June 30, 2010 was $79,427, a 25.5% per cent decrease\n from the quarter ended June 30, 2009. MedX incurred a loss for the\n quarter of $279,390 or $0.01 per share compared to a loss of $538,971 or\n $0.02 per share for the same period in the prior year.  Revenue for the\n first 6 months of 2010 was $245,466, a 46.4 per cent decrease over the\n same period in 2009.\n \n\n "We are continuing to rebuild our distribution base. The addition of the\n RJ Laser products are beginning to improve our revenues which will allow\n us to continue to expand our marketing initiatives, and we are seeking\n funding to accelerate this process, says Steve Guillen, president &\n CEO.  "Additionally, we recently announced a Letter of Intent (LOI) with\n Medical Marketing Berlin GmbH (MMB) for the exclusive North American\n marketing rights to the H'andy sana 211, a touch screen cell phone with\n an integrated ECG, a drug reminder and a 'Health Suite' in which blood\n glucose, cholesterol and blood pressure can be managed, and this will\n accelerate our revenue growth and improve our access to capital over the\n coming year," said Mr. Guillen.\n \n\n MedX Issues Shares for Debt\n \n\n MedX has also issued 5,668,307 million shares in settlement of\n $566,830.70 in obligations to several parties.  These shares are subject\n to a hold period expiring December 17, 2010. The number of fully diluted\n MedX Health Corp. shares outstanding is now 34,219,834 million.\n \n\n MedX Shareholders Meeting Date\n \n\n MedX further announced ...